Back to
SIMPLEX TRADING, LLC
BLRX3 quarters
Position history for
SIMPLEX TRADING, LLC's holdings in BIOLINE RX LIMITED
No. Simplex Trading exited its BLRX (Bioline RX) position in Q4 2025. Its Q3 2025 13F listed 105 shares. Simplex Trading first reported BLRX in Q2 2025 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$64,000
Total Shares Change
-14,114
Quarter-by-Quarter History
Other major holders of BLRX: CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC